Antiemetics: Technologies and Global Markets

Aug 2018| PHM070B| BCC Publishing

Report Highlights

The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.

Report Includes

  • 21 data tables and 15 additional tables
  • Country specific data and analysis for United States, Canada, Mexico, France, Germany, UK, China, India, Japan, and Middle East and Africa
  • An overview about current and future market potential for antiemetic drugs with special focus on competitive environment, pipeline drugs and blockbuster drugs
  • Coverage of disease burden, regulatory environment, and novel technologies in the antiemetic drugs market
  • Detailed description about vestibular disorder and increasing demand of innovative technology for treatment
  • Exploration of the causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting by each application segment
  • Information about the launching of new drugs in each antiemetic drug class such as 5 HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, and so forth
  • Detailed company profiles of major players in the market, including Abbott Laboratories, Daiichi Sankyo Company, Ltd., Merck & Co., Novartis AG, Sanofi Aventis and Teva Pharmaceutical Industries Ltd.

Report Scope

The report details the antiemetic drug market. The analysis highlights current and future market potential for antiemetic drug and presents a detailed review of pipeline drugs, blockbuster drugs, and challenges to market growth. The report also examines disease burden, regulatory environment, novel technologies, and market projections to 2023. Antiemetic drug market drivers, trends and potential regional market opportunities are also covered in this report.

The report details market shares of antiemetic drug class (5-HT3 receptor antagonists, dopamine antagonists, steroid-corticosteroids, benzodiazepines, NK1 receptor antagonist, antihistamines, cannabinoids, and anticholinergic) and geographic market segmentation of overall market; global market share by applications, with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for 2017, as base year, 2018 and forecast for 2023.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Antiemetics: Technologies and Global Markets 115 $2,750 Free
Chapter- 1: Introduction9Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Overview10$241Free
Chapter- 4: Market and Technology Background8$193Free
Chapter- 5: Market Breakdown by Drug Class20$482Free
Chapter- 6: Market Breakdown by Application7$169Free
Chapter- 7: Market Breakdown by Region10$241Free
Chapter- 8: Patent Review/New Developments3$72Free
Chapter- 9: Pipeline Analysis3$72Free
Chapter- 10: Regulatory Landscape8$193Free
Chapter- 11: Company Profiles33$796Free
Chapter- 12: Appendix: Abbreviations1$24Free
Published - Jan-2011| Analyst - Shalini Shahani Dewan| Code - PHM070A

Report Highlights

The global market for antiemetics was nearly $2.4 billion in 2009. There was a little setback seen in 2009 in the 5-HT3 category due to weakened economy and competition within brands and generics. The market for antiemetic products is expected to reach $2.5 billion by the end of 2010 and $3.6 billion by 2015, reflecting a 7.4% compound annual growth rate (CAGR).

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report